Bristol Myers Squibb has picked up a nod in the USA for its anemia med Reblozyl (luspatercept-aamt), a first-in-class therapy which promotes late-stage red bloo 30 August 2023
The US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the use of Veklury (remdesivir) with no dose adjustments t 24 August 2023
While Geron had hoped for a Priority Review for its rare blood cancer candidate imetelstat, the US regulator has confirmed a regular review will now take place, 23 August 2023
US pharma giant Pfizer’s Abrysvo has won US approval for use in pregnant women to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respi 22 August 2023
Gilead Sciences has been hit with a partial clinical hold by the US Food and Drug Administration (FDA) on the initiation of new patients in US studies evaluatin 21 August 2023
Neuroscience-focused Neurocrine Biosciences has won US Food and Drug Administration (FDA) approval for Ingrezza (valbenazine) capsules to treat adults with chor 21 August 2023
The US Food and Drug Administration (FDA) has told bluebird bio that an advisory committee (AdCom) meeting will not be scheduled for lovotibeglogene autotemcel 17 August 2023
French drugmaker Ipsen has won a landmark US approval of Sohonos (palovarotene) for an ultra-rare bone disease, having been rebuffed last month in its efforts t 17 August 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.